Hamza Celik
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Epigenetics and DNA Methylation 11
- Hematology 18
- Acute Myeloid Leukemia Research 16
- Chronic Myeloid Leukemia Treatments 3
- Multiple Myeloma Research and Treatments 2
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- Grant A. Challen (21 shared papers)Ashley C. Kramer (7 shared papers)Andrew Martens (5 shared papers)Cates Mallaney (10 shared papers)Elizabeth L. Ostrander (9 shared papers)Blanca Rodríguez (2 shared papers)Mira Jeong (2 shared papers)Margaret A. Goodell (2 shared papers)
- Journals
- Blood (10 papers)Experimental Hematology (2 papers)Leukemia (2 papers)Cell Reports (1 paper)Nature Cancer (1 paper)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Hamza Celik
22 papers receiving 942 citations
Peers
Comparison fields: 5 of 66
- Hematology 372
- Genetics 153
- Aging 24
- Molecular Biology 713
- Cancer Research 99
Countries citing papers authored by Hamza Celik
This map shows the geographic impact of Hamza Celik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamza Celik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamza Celik more than expected).
Fields of papers citing papers by Hamza Celik
This network shows the impact of papers produced by Hamza Celik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamza Celik. The network helps show where Hamza Celik may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamza Celik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 261 | |
| 2 | 2016 | 209 | |
| 3 | 2018 | 156 | |
| 4 | 2014 | 78 | |
| 5 | 2019 | 45 | |
| 6 | 2018 | 40 | |
| 7 | 2017 | 36 | |
| 8 | 2022 | 30 | |
| 9 | 2016 | 27 | |
| 10 | 2022 | 24 | |
| 11 | 2022 | 15 | |
| 12 | 2021 | 12 | |
| 13 | 2020 | 3 | |
| 14 | 2014 | 2 | |
| 15 | 2021 | 2 | |
| 16 | 2023 | 2 | |
| 17 | 2016 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2021 | 1 |
About Hamza Celik
Hamza Celik is a scholar working on Molecular Biology, Hematology, Genetics, Public Health, Environmental and Occupational Health and Cancer Research, having authored 24 papers that have together received 949 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Epigenetics and DNA Methylation (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Hematology (372 citations), Genetics (153 citations), Aging (24 citations), Molecular Biology (713 citations) and Cancer Research (99 citations). Hamza Celik has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Grant A. Challen, Ashley C. Kramer, Andrew Martens, Cates Mallaney, Elizabeth L. Ostrander, Blanca Rodríguez, Mira Jeong, Margaret A. Goodell, John R. Edwards and James I. McDonald. Their work appears in journals such as Blood, Experimental Hematology, Leukemia, Cell Reports and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.